AstraZeneca and IDT Biologika recently partnered to boost manufacturing and supply capacity for COVID-19 Vaccine AstraZeneca in the second quarter of 2021.
The companies will also launch a joint...
CVS Health recently announced that it is expanding access to COVID-19 vaccines to eligible populations at a limited number of CVS Pharmacy locations across 11 states.
In total, there will be...
GSK and CureVac recently announced a $180.5 million collaboration to jointly develop next-generation mRNA COVID-19 vaccines.
The companies will contribute resources and expertise to research, develop,...
HHS recently issued a fifth amendment to the Declaration under the Public Readiness and Emergency Preparedness Act (PREP Act) to add categories of qualified persons authorized to prescribe,...
AstraZeneca recently announced that its COVID-19 vaccine is safe and effective at preventing coronavirus in Phase 3 clinical trials from the UK, Brazil, and South Africa.
The first dose of...
Pfizer and BioNTech recently announced an advanced purchase agreement with COVAX for up to 40 million doses of its mRNA COVID-19 vaccine, BNT162b2.
The first doses of the vaccine are expected to be...
Johnson & Johnson recently announced that a single-dose of its COVID-19 vaccine candidate, Ad26.COV2.S, was 66 percent effective at preventing moderate to severe coronavirus in a Phase 3 clinical...
Novavax recently announced that its COVID-19 vaccine candidate, NVX-CoV2373, was 89.3 percent effective in the Phase 3 UK clinical trial.
The trial also found that the vaccine was 95.6 percent...
Moderna recently announced that clinical trial researchers have dosed the first in the Phase 1/2 study of its mRNA COVID-19 vaccine, mRNA-1273, in Japan, led by Takeda Pharmaceuticals.
The...
FDA recently approved ViiV Healthcare’s Cabenuva, the first and only complete long-acting injectable HIV treatment for positive adults.
The drug will be administered to HIV-positive adults...
Merck recently announced that it is discontinuing development of its COVID-19 vaccine candidates, V590 and V591, and will focus its research strategy on advancing its two other candidates, MK-4482 and...
Pfizer and BioNTech recently announced that its COVID-19 vaccine, BNT162b2, elicited antibodies that neutralize the SARS-CoV-2 UK strain, known as B.1.1.7 lineage.
The in-vitro study...
The US will remain a member of the World Health Organization (WHO) under President Joe Biden and will join COVAX, a global COVID-19 vaccine program led by WHO, NIAID Director Anthony Fauci, MD, said in...
Future industry-wide trends for pharmaceutical companies and manufacturers are taking root as the industry continues to respond to the COVID-19 pandemic.
Listen to the full podcast to hear...
President Joe Biden recently signed an executive order to combat COVID-19 and prepare for future biological and pandemic threats.
“The Federal Government must act swiftly and aggressively...
Recently, experts have considered delaying, skipping, or half-dosing Moderna and Pfizer-BioNTech’s COVID-19 vaccines to reach more people in need and create a more wide-spread...
Moderna recently announced that Swissmedic, the Swiss Agency for therapeutic products, has authorized its mRNA-based COVID-19 vaccine for use in Switzerland.
The Swiss authorization comes over a month...
COVID-19 vaccine distribution has begun across the country. But government officials are not the only ones making difficult decisions about the logistics of vaccine rollout. Health system leaders must...
Every January the J.P. Morgan Healthcare Conference is a major event for the pharmaceutical industry, as it brings together experts from across the sector and covers important announcements from top...
Kaiser Permanente Vaccine Study Center, part of the company’s Northern California Division of Research, recently announced that it will oversee electronic patient records and uncover any adverse...
